Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Additional funding awarded to Cancer Drugs Fund: Macmillan response

  • Comment

Macmillan cancer support response to the extension of the Cancer Drugs Fund

Responding to the Prime Minister David Cameron’s announcement that the Cancer Drugs Fund will receive additional funding of £400million to extend it until March 2016, Mike Hobday, Director of Policy & Research at Macmillan Cancer Support, says:

“We are delighted that the Government has decided to extend the Cancer Drugs Fund by a further two years. In 2010, we campaigned to secure this funding so that more cancer patients would be able to access life-prolonging and vital treatment.

“Since then, tens of thousands of people have been able to get the most effective cancer drugs no matter where they are from or which cancer they have. Today’s announcement means that many more can be helped.

“However the Government must ensure that all drugs available through the fund will be available through the NHS after 2016. We have to avoid a return to the bad old days when cancer patients were denied lifesaving drugs simply because of where they lived or that they had a rarer cancer.”

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs